Alves et al. (2016) [51] mention that leptin, ghrelin, and glucagon-like peptide-1 are pharmacologically relevant, since these hormones regulate glucose homeostasis in the body and may be ideal targets for anti-obesity therapy. The gene discussed is LEP; the disease is obesity due to melanocortin 4 receptor deficiency.